BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32005002)

  • 1. Progression of coronary calcium burden and carotid stiffness in patients with essential thrombocythemia associated with JAK2 V617F mutation.
    Anžič Drofenik A; Vrtovec M; Božič Mijovski M; Sever M; Preložnik Zupan I; Kejžar N; Blinc A
    Atherosclerosis; 2020 Mar; 296():25-31. PubMed ID: 32005002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the prevalence and prospective clinical impact of the JAK2 V617F mutation in coronary patients.
    Muendlein A; Gasser K; Kinz E; Stark N; Leiherer A; Rein P; Saely CH; Grallert H; Peters A; Drexel H; Lang AH
    Am J Hematol; 2014 Mar; 89(3):295-301. PubMed ID: 24265174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid Artery Stiffness, Digital Endothelial Function, and Coronary Calcium in Patients with Essential Thrombocytosis, Free of Overt Atherosclerotic Disease.
    Vrtovec M; Anzic A; Zupan IP; Zaletel K; Blinc A
    Radiol Oncol; 2017 Jun; 51(2):203-210. PubMed ID: 28740456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of JAK2
    Latagliata R; Polverelli N; Tieghi A; Palumbo GA; Breccia M; Sabattini E; Villari L; Riminucci M; Valli R; Catani L; Alimena G; Ottaviani E; Fama A; Martinelli G; Perricone M; Spinsanti M; Cavo M; Vianelli N; Palandri F
    Hematol Oncol; 2018 Feb; 36(1):269-275. PubMed ID: 28509339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between carotid atherosclerosis and coronary artery calcification in asymptomatic diabetic patients: A prospective multicenter study.
    Jeevarethinam A; Venuraju S; Dumo A; Ruano S; Mehta VS; Rosenthal M; Nair D; Cohen M; Darko D; Lahiri A; Rakhit R
    Clin Cardiol; 2017 Sep; 40(9):752-758. PubMed ID: 28543093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia.
    Nakatani T; Imamura T; Ishida H; Wakaizumi K; Yamamoto T; Otabe O; Ishigami T; Adachi S; Morimoto A
    Pediatr Blood Cancer; 2008 Dec; 51(6):802-5. PubMed ID: 18802948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Cacciola E; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Leone G; Barbui T;
    Ann Hematol; 2010 Feb; 89(2):141-6. PubMed ID: 19582452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.
    Musolino C; Allegra A; Penna G; Centorrino R; Cuzzola M; D'Angelo A; Iacopino P; Alonci A
    Acta Haematol; 2009; 122(1):46-9. PubMed ID: 19816006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
    Hussein K; Bock O; Theophile K; von Neuhoff N; Buhr T; Schlué J; Büsche G; Kreipe H
    Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between carotid disease on ultrasound and coronary disease on CT angiography.
    Cohen GI; Aboufakher R; Bess R; Frank J; Othman M; Doan D; Mesiha N; Rosman HS; Szpunar S
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1160-7. PubMed ID: 24229768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study.
    Sillesen H; Muntendam P; Adourian A; Entrekin R; Garcia M; Falk E; Fuster V
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):681-9. PubMed ID: 22789936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired JAK-2 V617F Mutational Analysis in Pakistani Patients with Essential Thrombocythemia.
    Sultan S; Irfan SM
    Asian Pac J Cancer Prev; 2015; 16(16):7327-30. PubMed ID: 26514532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound carotid intima-media thickness, carotid plaque and cardiac calcium incrementally add to the Framingham Risk Score for the prediction of angiographic coronary artery disease: a multicenter prospective study.
    Gaibazzi N; Rigo F; Facchetti R; Carerj S; Giannattasio C; Moreo A; Mureddu G; Paini A; Grolla E; Faden G; Cesana F; Faggiano P
    Int J Cardiol; 2014 Dec; 177(2):708-10. PubMed ID: 25449491
    [No Abstract]   [Full Text] [Related]  

  • 14. High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burden.
    Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
    Hematology; 2008 Apr; 13(2):71-6. PubMed ID: 18616871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis.
    Gepner AD; Young R; Delaney JA; Tattersall MC; Blaha MJ; Post WS; Gottesman RF; Kronmal R; Budoff MJ; Burke GL; Folsom AR; Liu K; Kaufman J; Stein JH
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25596139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid stiffness and atherosclerotic risk: non-invasive quantification with ultrafast ultrasound pulse wave velocity.
    Zhu ZQ; Chen LS; Wang H; Liu FM; Luan Y; Wu LL; Liu N; Wang P; Huang H
    Eur Radiol; 2019 Mar; 29(3):1507-1517. PubMed ID: 30187117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera.
    Rottenstreich A; Kleinstern G; Krichevsky S; Varon D; Lavie D; Kalish Y
    Eur J Intern Med; 2017 Jun; 41():49-54. PubMed ID: 27919526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patients.
    Chim CS; Sim JP; Chan CC; Kho BC; Chan JC; Wong LG; Law M; Liang R; Kwong YL
    Hematology; 2010 Aug; 15(4):187-92. PubMed ID: 20670476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
    Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
    Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.